Sirana collaborates with Pfizer to probe novel treatment options for bone diseases

Moreover, it will initially involve utilising Sirana’s proprietary microRNA approach, which targets substantial regenerative recovery of diseased muscle and bone tissue.

Sirana, Pfizer, bone diseases, bone disorders, health news, pharma news,
Reportedly, the partnership will help them in investigating the potential identification and validation of bone diseases. (Image Credit: Pixabay)

Sirana Pharma on Thursday announced a collaborative research agreement with pharma giant Pfizer. According to the company, the partnership will help them in investigating the potential identification and validation of a novel treatment concept for rare and debilitating bone diseases. Moreover, it will initially involve utilising Sirana’s proprietary microRNA approach, which targets substantial regenerative recovery of diseased muscle and bone tissue.

“Combining Sirana’s novel miRNA-targeting approach, and the long-standing experience in musculoskeletal disorders and disease mechanisms of its founders, with the expertise and competencies of Pfizer, will allow Sirana to expeditiously evaluate its drug candidates for the treatment of this rare disease and to identify potential candidates for further development,” Michael Kring, chief executive officer of Sirana Pharma said.

“At Pfizer, we are committed to advancing promising, emerging research – both through our internal capabilities and through collaborations with companies like Sirana – with the goal of bringing potentially life-changing medicines to patients around the world,” said Seng Cheng, senior vice president at Pfizer Rare Disease.

“We look forward to working together with the Sirana team to further explore this new and innovative investigational approach, utilizing miRNA-targeting for the potential treatment of rare bone diseases,” he added.

Sirana has focused on the development of first-in-class molecules to treat both Sarcopenia – age-related muscle weakness – and osteogenesis imperfecta, an inherited brittle bone disease.

Get live Share Market updates and latest India News and business news on Financial Express. Download Financial Express App for latest business news.

Most Read In News Healthcare
Photos